The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer

Anticancer Research

Volumn 32, Issue 2, 2012, Pages 559-564

  Choi, Jongsoon ^a   Chang, HeeKyung ^a  

^a Kosin University   (South Korea)

Author keywords

Colorectal cancer; COX2; Liver metastasis; MAGE; SSX; VEGF

Indexed keywords

CYCLOOXYGENASE 2; MELANOMA ANTIGEN; PARAFFIN; SURVIVIN; VASCULOTROPIN;

ADENOCARCINOMA; ADULT; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL SARCOMA; X CHROMOSOME;

COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; MALE; MELANOMA-SPECIFIC ANTIGENS; MIDDLE AGED; NEOPLASM PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863169550     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Akers SN, Odunsi K and Karpf AR: Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy. Future Oncol 6(5): 717-732, 2010.
2. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM, Gusterson BA and Cooper CS: Identification of novel genes, SYT and SSX, involved in the t(X:18) (p11.2;q11.2) translocation found in human synovial Genet 7(4): 502-508, 1994.
3. Smith HA, Cronk RJ, Lang JM and McNeel DG: sarcoma. Nature, expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer. Cancer Res 71(21): 6785-6795, 2011.
4. Smith HA and McNeel DG: Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T-cells. J Immunother 34(8): 569-580, 2011.
5. Gure AO, Wei IJ, Old LJ and Chen YT: The SSX gene family; characterization of 9 complete genes. Int J Cancer 101(5): 448-453, 2002.
6. Ayyoub M, Brehm M, Metthez G, Talbot S, Dutoit V, Taub RN, Keohan M-L, Gure AO, Chen Y-T, Williamson B, Jungbluth AA, Old LJ and Hesdorffer CS and Valmori D: SSX antigens as tumor vaccine targets in human sarcoma. Cancer Immun 3: 13, 2003.
7. dos Santos NR, de Bruijn DR and van Kessel AG: Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 30(1): 1-14, 2001.
8. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8): 917-921, 1997. (Pubitemid 27353455)
9. Porebska I, Sobańska E, Kosacka M and Jankowska R: Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer. Cancer Genomics Proteomics 7(6): 331-335, 2010.
10. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M and Tanigawa N: Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6(1): 127-134, 2000. (Pubitemid 30064984)
11. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J and Fujii Y: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95(2): 92-95, 2001. (Pubitemid 32187079)
12. Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M and Takano Y: Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163(1): 109-116, 2001. (Pubitemid 32121836)
13. Wu AW, GU J, Li ZF, Ji JF and Xu GW: Cox-2 expression and tumor angiogenesis in colorectal cancer World J Gastroenterol 10(16): 2323-2326, 2004.
14. Cianchi F, Cortesini C, Fantappie O, Messerin L, Sardi I, Lasagna N, Perna F, Fabbroni V, Di Felice A, Perigli G, Mazzanti R and Masini E: Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin Cancer Res 10(8): 2694-2704, 2004. (Pubitemid 38509144)
15. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J and Bouvier AM: Epidmiology and management of liver metastases from colorectal cancer. Ann Surg 244(2): 254-259, 2006. (Pubitemid 44305540)
16. Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES, Chapiro J, Van Den Eynde BJ, Brasseur F and Boon T: Tumor-specific shared antigenic peptides recognized by human T-cells. Immunol Rev 188: 51-64, 2002. (Pubitemid 35398865)
17. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T and Lucas S: An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61(14): 5544-5551, 2001. (Pubitemid 32694940)
18. Caballero OL and Chen YT: Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100(11): 2014-2021, 2009.
19. Van den Eynde B, Peeters O, De backer O, Gaugler B, Lucas S and Boon T: A new family of genes coding for an antigen recognized by autologous cytolytic lymphocytes on a human melanomas. J Exp Med 182(3): 689-698, 1995.
20. Tureci O, Chen YT, Sahin U, Gure AO, Zwick C, Villena C, Tsang S, Seitz G, Old LJ and Pfreundschuh M: Expression of SSX genes in human tumors. Int. J Cancer 77(1): 19-23, 1998. (Pubitemid 28308546)
21. Hasegawa H, Mori M, Haraguchi M, Ueo H, Sugimachi K and Akiyoshi T: Expression spectrum of melanoma antigen-encoding gene family members in colorectal carcinoma. Arch Pathol Lab Med 122(6): 551-554, 1998. (Pubitemid 28262188)
22. Jeon CH, Kim DD, Lee HI, Oh HK and Chae HD: Melanoma-associated antigen (MAGE) expression in the normal mucosa around colorectal cancer after curative resection: presence of undetectable free cancer cells. Int J Biol Markers 26(2): 88-93, 2011.
23. Ming Li, Yan-Hua Yuan, Yan Han, Yue-Xiang Liu, Li Yan, Yu Wang and Jin Gu: Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Clin Cancer Res 11: 1809-1814, 2005.
24. Ishizaki T, Katsumata K, Tsuchida A, Wada T, Mori Y, Hisada M, Kawkita H and Aoki T: Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity. Int J Mol Med 17: 357-362, 2006.
25. Xiong B, Sun TJ, Hu MD, Cheng FL, Mao M and Zhou YF: Expression of COX-2 in colorectal cancer and its clinical significance. World J Gastroenterol 11: 1105-1108, 2005. (Pubitemid 40352994)
26. Galizia G, Lieto E, Ferraraccio F, Orditura M, De Vita F, Castellano P, Imperatore V, Romano C, Ciardiello F, Agostini B and Pignatelli C: Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 10(10): 3490-3499, 2004. (Pubitemid 38685457)
27. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N and Nakamura M: Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77(6): 998-1002, 1998. (Pubitemid 28101792)